CRISPR

CRISPR2-fads2

ID

ZDB-CRISPR-210513-1

Name

CRISPR2-fads2

Previous Names

None

Target

Sequence

5' - GCCGCTGCTAATCGGAGAGC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
zf3386	fads2

Expression

Gene expression in Wild Types + CRISPR2-fads2

No data available

Phenotype

Phenotype resulting from CRISPR2-fads2

No data available

Phenotype of all Fish created by or utilizing CRISPR2-fads2

Phenotype	Fish	Conditions	Figures
liver saturated fatty acid decreased amount, abnormal	fads2^{zf3386/zf3386} (AB)	standard conditions	Fig. 1 from Zhao et al., 2020
liver linoleic acid increased amount, abnormal	fads2^{zf3386/zf3386} (AB)	standard conditions	Fig. 1 from Zhao et al., 2020
liver fads2 expression decreased amount, abnormal	fads2^{zf3386/zf3386} (AB)	standard conditions	Fig. 1 from Zhao et al., 2020
liver alpha-linolenic acid increased amount, abnormal	fads2^{zf3386/zf3386} (AB)	standard conditions	Fig. 1 from Zhao et al., 2020
liver docosapentaenoic acid increased amount, abnormal	fads2^{zf3386/zf3386} (AB)	standard conditions	Fig. 1 from Zhao et al., 2020
liver all-cis-octadeca-6,9,12,15-tetraenoic acid decreased amount, abnormal	fads2^{zf3386/zf3386} (AB)	standard conditions	Fig. 1 from Zhao et al., 2020
liver gamma-linolenic acid decreased amount, abnormal	fads2^{zf3386/zf3386} (AB)	standard conditions	Fig. 1 from Zhao et al., 2020
liver docosahexaenoic acid decreased amount, abnormal	fads2^{zf3386/zf3386} (AB)	standard conditions	Fig. 1 from Zhao et al., 2020
liver polyunsaturated fatty acid increased amount, abnormal	fads2^{zf3386/zf3386} (AB)	standard conditions	Fig. 1 from Zhao et al., 2020

Citations